Working… Menu
Trial record 2 of 3 for:    IDX-1197

Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03317743
Recruitment Status : Active, not recruiting
First Posted : October 23, 2017
Last Update Posted : January 15, 2021
IlDong Pharmaceutical Co Ltd
National OncoVenture
Information provided by (Responsible Party):
Idience Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 8, 2020
Estimated Study Completion Date : June 2021